[Prostaglandins in uterine atony].
I. Universitäts Frauenklinik Wien.
P
P
Husslein
D015237:Dinoprost / Q000627:therapeutic use; D015232:Dinoprostone / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006473:Postpartum Hemorrhage / Q000209:etiology / Q000517:prevention & control; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage / Q000627:therapeutic use*; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use; D011644:Puerperal Disorders / Q000188:drug therapy*; D014593:Uterine Inertia / Q000150:complications / Q000188:drug therapy*
D011453:Prostaglandins; D011459:Prostaglandins E, Synthetic; D011461:Prostaglandins F, Synthetic; D015237:Dinoprost; D015232:Dinoprostone
Prostaglandine bei postpartaler Atonie.